Effect of diet therapy in treatment of patients with polycystic ovary syndrome

Phase 3

• Conditions: Polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT201701295623N104
• Lead Sponsor: Vice chancellor for research, Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Aged18–40 years old
Patients with PCOS according to Rotterdam criteria

Exclusion Criteria

Pregnant women
Hyperprolactinaemia
Thyroid dysfunction
Endocrine diseases including diabetes, impaired glucose tolerance and gastrointestinal problems
Took medications, such as hormonal contraceptives, insulin sensitising agents, anti-inflammatory or antidiabetic and lipid lowering drugs, or any other medications that might affect reproductive physiology during the 8-week intervention.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Using HOMA formula.;Insulin sensitivity. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Using QUICKI formula.